These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16211707)

  • 21. Nesiritide as an adjunctive therapy in adult patients with heart failure undergoing high-risk cardiac surgery.
    Samuels LE; Holmes EC; Lee L
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):627-9. PubMed ID: 15457170
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: Critical review and recommendations for nesiritide use in the Emergency Department.
    Levine M
    J Emerg Med; 2007 Feb; 32(2):207-8; author reply 208-9. PubMed ID: 17307636
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemodynamic effects and safety of nesiritide in neonates with heart failure.
    Simsic JM; Mahle WT; Cuadrado A; Kirshbom PM; Maher KO
    J Intensive Care Med; 2008; 23(6):389-95. PubMed ID: 18805856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
    Riter HG; Redfield MM; Burnett JC; Chen HH
    J Am Coll Cardiol; 2006 Jun; 47(11):2334-5. PubMed ID: 16750705
    [No Abstract]   [Full Text] [Related]  

  • 26. Medicare coverage of tumor necrosis factor alpha inhibitors as an influence on physicians' prescribing behavior.
    DeWitt EM; Glick HA; Albert DA; Joffe MM; Wolfe F
    Arch Intern Med; 2006 Jan; 166(1):57-63. PubMed ID: 16401811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of a large nesiritide bolus dose in a pediatric patient: case report and review of nesiritide use in pediatrics.
    Moffett BS; Jefferies JL; Price JF; Clunie S; Denfield S; Dreyer WJ; Towbin JA
    Pharmacotherapy; 2006 Feb; 26(2):277-80. PubMed ID: 16466333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nesiritide: past, present, and future.
    Burger AJ; Burger MR
    Minerva Cardioangiol; 2005 Dec; 53(6):509-22. PubMed ID: 16333235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
    Schwarz ER; Najam S; Akel R; Sulimanjee N; Bionat S; Rosanio S
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):232-6. PubMed ID: 17875951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nesiritide--not verified.
    Sackner-Bernstein J; Aaronson KD
    N Engl J Med; 2005 Oct; 353(14):1525-7; author reply 1525-7. PubMed ID: 16207860
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience with nesiritide at a community hospital.
    Olin JL; Chan A
    Am J Health Syst Pharm; 2004 Jul; 61(13):1337-8. PubMed ID: 15287225
    [No Abstract]   [Full Text] [Related]  

  • 33. Maintaining and optimising anti-TNF therapy.
    Somerville M
    Musculoskeletal Care; 2007 Dec; 5 Suppl 1():1-17. PubMed ID: 18050263
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rituximab (MabThera) as treatment of active rheumatoid arthritis].
    El Fassi D; Nielsen CH; Bendtzen K
    Ugeskr Laeger; 2006 Nov; 168(47):4079-81. PubMed ID: 17134602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliability of nesiritide infusion via non-primed tubing and heparin-coated catheters.
    Onat D; Stathopoulos J; Rose A; Newman K; Sciacca RR; Jorde UP; Colombo PC
    Ann Pharmacother; 2005 Oct; 39(10):1617-20. PubMed ID: 16159995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-type natriuretic peptides in management of acute decompensated heart failure.
    Yancy CW
    Heart Fail Clin; 2006 Jul; 2(3):353-64. PubMed ID: 17386904
    [No Abstract]   [Full Text] [Related]  

  • 37. Nesiritide as bridge to multi-organ transplantation: a case report.
    Cochrane AB; Fedson SE; Cronin DC
    Transplant Proc; 2007; 39(1):308-10. PubMed ID: 17275531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain natriuretic peptide: a diagnostic and treatment hormone for perioperative congestive heart failure.
    Skidmore KL; Russell IA
    J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):780-7. PubMed ID: 15650995
    [No Abstract]   [Full Text] [Related]  

  • 40. Introduction: optimizing heart failure management.
    Heywood JT
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S1-2. PubMed ID: 15627914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.